Informed Consent Form 1 Sample Clauses

Informed Consent Form 1. 2. Informovaný súhlas Institution acknowledges that Investigator shall use an informed consent form that has been approved by Sponsor and is in accordance with applicable regulations and the requirements of the Independent Ethics Committee (“IEC”) that is responsible for reviewing the Study. Zdravotnícke zariadenie potvrdzuje, že skúšajúci použije dokument informovaného súhlasu, ktorý bol schválený zadávateľom a spĺňa všetky platné nariadenia a požiadavky nezávislej etickej komisie, ktorá je zodpovedná za posúdenie skúšania.
AutoNDA by SimpleDocs
Informed Consent Form 1. 2. Informovaný súhlas Site agrees to use an informed consent form that has been approved by Sponsor and is in accordance with applicable regulations and the requirements of the Institutional Review Board (“IRB”) or Independent Ethics Committee (“IEC”) that is responsible for reviewing the Study. Site shall obtain the prior written informed consent of each Study Subject. Pracovisko skúšania sa zaväzuje použiť dokument informovaného súhlasu, ktorý bol schválený zadávateľom a spĺňa všetky platné nariadenia a požiadavky nezávislej etickej komisie, ktorá je zodpovedná za posúdenie skúšania. Pracovisko skúšania najprv získa od každého subjektu skúšania písomný informovaný súhlas.
Informed Consent Form 1. 3 Formuláš písemného informovaného souhlasu Site agrees to use a paper informed consent that has been approved by Sponsor and is in accordance with Applicable Law and the requirements of the Ethics Committee for Multicentrics Trials (“ECMT”) and Local Ethics Committees (“LEC”), jointly Ethics Committees (“EC”) that is responsible for reviewing the Study. Site shall obtain the informed consent of each Study Subject, prior to any such Study Subject’s enrollment in the Study or participation in Místo provádení klinického hodnocení souhlasí s tím, že bude používat tištený formuláš informovaného souhlasu, , ve znení schváleném Zadavatelem, a který je v souladu s Pšíslušnými právními pšedpisy a požadavky Etické komise pro multicentrická hodnocení („MEK“) a Místních etických komisí („LEK“), společne dále jen Etických komisí („EK“), které jsou zodpovedné za kontrolu Studie. Místo provádení klinického hodnocení zajistí informovaný souhlas každého any Study-related activity, survey, or other requirement. Under no circumstance shall Site give to IQVIA or Sponsor any specific information related to Study Subjects who do not provide informed consent. Subjektu studie ješte pšed zašazením daného Subjektu studie do Studie nebo pšed jeho účastí na jakémkoli úkonu, průzkumu či jiné požadované činnosti v souvislosti se Studií. Místo provádení klinického hodnocení za žádných okolností nepšedá společnosti IQVIA ani Zadavateli žádné konkrétní informace týkající se Subjektů studie, které neposkytnou informovaný souhlas.
Informed Consent Form 1. 2. Formulář písemného informovaného souhlasu Site agrees to use an informed consent form that has been approved by Sponsor and is in accordance with applicable regulations and the requirements of the Ethics Committee for Multicentrics Trials (“ECMT”) and Local Ethics Committees (“LEC), jointly Ethics Committees (“EC”) that is responsible for reviewing the Study. Investigator shall obtain the prior written informed consent of each Study Subject. For the purposes of this Study Sponsor undertakes to provide Investigator with an informed consent form template which meets all of the legal and Study Protocol requirements. Místo provádění klinického hodnocení souhlasí s tím, že bude používat formulář informovaného souhlasu, ve znění schváleném Zadavatelem, a který je v souladu s příslušnými právními předpisy a požadavky Etické komise pro multicentrická hodnocení (“MEK”) a Místních etických komisí (“LEK), společně dále jen Etických komisí (“EK”), které jsou zodpovědné za kontrolu Studie. Zkoušející předem zajistí písemný informovaný souhlas každého Subjektu studie. Zadavatel se zavazuje předat Zkoušejícímu pro účely Studie vzorový informovaný souhlas, který obsahuje veškeré shora uvedené požadavky.
Informed Consent Form 1. 2. Informovaný súhlas Site shall obtain the prior written informed consent of each Study Subject for the participation in a Study as well as for the processing of personal data from the Study Subject including the public disclosure, transfer and processing of data collected in accordance with the Protocol, in compliance with Applicable Data Protection Laws. For that purpose, the Institutionacknowledges that Investigator shall use an informed consent form that has been approved by Sponsor and is in accordance with applicable regulations and the requirements of the Independent Ethics Committee (“IEC”) that is responsible for reviewing the Study and which will be provided by IQVIAto the Site. The informed consent form will provide information about rights of patients and data processing according to applicable data protection provisions. The informed consent form will also designate Site as the point of contact for any data protection related requests concerning Site, IQVIA or Sponsor in connection with the Study and Site will be primarily responsible to handle such requests (including sharing such requests with Sponsor and IQVIA, where required) and communicate with patients; Sponsor and IQVIA will provide reasonable assistance where required to ensure compliance with patients' rights under Applicable Data Protection Laws.. Pracovisko skúšania xxxxx xx každého subjektu skúšania predchádzajúci písomný informovaný súhlas s účasťou na skúšaní, ako aj so spracovávaním osobných údajov subjektu skúšania zahŕňajúcim odovzdávanie, prenos a spracovávanie údajov zozbieraných v súlade s protokolom a platnými právnymi predpismi o ochrane osobných údajov. Na tento účel zdravotnícke zariadenie potvrdzuje, že skúšajúci použije dokument informovaného súhlasu, ktorý bol schválený zadávateľom a spĺňa všetky platné nariadenia a požiadavky nezávislej etickej komisie, ktorá je zodpovedná za posúdenie skúšania,a ktorý poskytne spoločnosť IQVIA pracovisku skúšania. V informovanom súhlase budú uvedené informácie o právach pacientov a spracovávaní údajov v súlade s ustanoveniami platných právnych predpisov o ochrane osobných údajov. V informovanom súhlase sa tiež pracovisko skúšania označí ako kontaktné miesto všetkých žiadostí súvisiacich s ochranou osobných údajov týkajúcich sa pracoviska skúšania, spoločnosti IQVIA alebo zadávateľa v súvislosti so skúšaním a pracovisko skúšania bude primárne zodpovedať za vybavovanie takýchto žiadostí (vrátane odovzdávania týchto žiadostí zadávat...
Informed Consent Form 1. 2Formulář písemného informovaného souhlasu Site agrees to use an informed consent form that has been approved by Sponsor and is in accordance with applicable regulations and the requirements of the Ethics Committee for Multicentrics Trials (“ECMT”) and Local Ethics Committees (“LEC”), jointly Ethics Committees (“EC”) that is responsible for reviewing the Study. Site shall obtain the prior written informed consent of each Study Subject. Místo provádění klinického hodnocení souhlasí s tím, že bude používat formulář informovaného souhlasu, ve znění schváleném Zadavatelem, a který je v souladu s příslušnými právními předpisy a požadavky Etické komise pro multicentrická hodnocení („MEK“) a Místních etických komisí („LEK“), společně dále jen Etických komisí („EK“), které jsou zodpovědné za kontrolu Studie. Místo provádění klinického hodnocení předem zajistí písemný informovaný souhlas každého Subjektu studie.
Informed Consent Form 1. 2 Formulář informovaného souhlasu Site agrees to use an informed consent form that has been provided by Sponsor and is in accordance with applicable regulations and the requirements of the Ethics Committee for Multicentrics Trials (“ECMT”) and Local Ethics Committees (“LEC”), jointly Ethics Committees (“EC”) that is responsible for reviewing the Study. Investigator shall obtain the written informed consent of each Study Subject prior to performing any Study procedures. Místo provádění klinického hodnocení souhlasí s tím, že bude používat formulář informovaného souhlasu, ve znění dodaném Zadavatelem, a který je v souladu s příslušnými právními předpisy a požadavky Etické komise pro multicentrická hodnocení („MEK“) a Místních etických komisí („LEK“), společně dále jen Etických komisí („EK“), které jsou zodpovědné za kontrolu Studie. Zkoušející před provedením jakýchkoli úkonů pro účely Studie zajistí písemný informovaný souhlas každého Subjektu studie.
AutoNDA by SimpleDocs
Informed Consent Form 1. 2. Informovaný súhlas Institution acknowledges that Investigator shall use an informed consent form (“ICF”) that has been reviewed by Sponsor and is approved by and in accordance with applicable regulations and the requirements of the Independent Ethics Committee (“IEC”) that is responsible for reviewing the Study. Prior to a Study Subject participating in the Study, a properly Zdravotnícke zariadenie potvrdzuje, že skúšajúci použije dokument informovaného súhlasu, ktorý skontroloval zadávateľ a je schválený a spĺňa všetky platné nariadenia a požiadavky nezávislej etickej komisie, ktorá je zodpovedná za posúdenie skúšania. Pred účasťou subjektu na skúšaní sa má od takéhoto subjektu skúšania získať náležite podpísaný VXA34987 CTA Template Slovakia INST 6Dec2016- based on IQVIA Global template – 15 April 2013 PI: Xxxxx Xxxxx, MD VXA34987 CTA Template Slovakia INST 6Dec2016- based on IQVIA Global template – 15 April 2013 executed ICF should be obtained from such Study Subject. informovaný súhlas.

Related to Informed Consent Form 1

  • Informed Consent Both of us have reviewed this Agreement with independent legal counsel. We understand the content, legal effect, and consequences of this Agreement, and we are entering into this Agreement voluntarily, free from duress, fraud, undue influence, or coercion of any kind.

  • Notification Regarding Letting/Transfer If the Allottee lets out or transfers the said Apartment, the Allottee shall immediately notify the Promoter/Association (upon formation) of the tenant’s/transferee's address and telephone number.

  • No Conflict; Required Filings and Consents (a) The execution and delivery of this Agreement by the Company do not, and the performance of this Agreement by the Company and the consummation of the Mergers (subject to the approval of this Agreement, the Mergers and the other transactions contemplated hereby by the Company Required Vote) and the other transactions contemplated by this Agreement will not, (i) conflict with or violate any provision of the Company Memorandum, or the equivalent organizational documents of any Subsidiary of the Company, (ii) assuming that all consents, approvals, authorizations and waivers contemplated by Section 4.05(b) have been obtained, and all filings described therein have been made, and assuming the accuracy and completeness of the representations and warranties contained in Section 5.05(b), conflict with or violate any Law applicable to the Company or its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected, (iii) require any consent or other action by any Person under, result in a breach of or constitute a default (or an event that with notice or lapse of time or both would become a default) under, give to others (immediately or with notice or lapse of time or both) any right of termination, amendment, acceleration or cancellation of, result (immediately or with notice or lapse of time or both) in triggering any payment or other obligations under, or result in the loss of any right or benefit to which the Company or any of its Subsidiaries is entitled under, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation or authorization (each, a “Contract”) to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries, or any property or asset of the Company or any of its Subsidiaries, is bound or affected or (iv) result (immediately or with notice or lapse of time or both) in the creation of a Lien on any property or asset of the Company or its Subsidiaries, except in the case of clauses (ii), (iii) and (iv) for any such conflicts, violations, breaches, defaults or other occurrences that would not, individually or in the aggregate, reasonably be likely to have a Company Material Adverse Effect.

  • AUTHORIZATION AND CONSENT The Government has given its authorization and consent for all use and manufacture of any invention described in and covered by a patent of the United States in the performance of this Agreement or any part hereof or any amendment hereto or any subcontract hereunder (including any lower-tier subcontract) which is expected to exceed $100,000.

  • Form 700 Filing The California Political Reform Act and the Chula Vista Conflict of Interest Code require certain government officials and consultants performing work for government agencies to publicly disclose certain of their personal assets and income using a Statement of Economic Interests form (Form 700). In order to assure compliance with these requirements, Consultant shall comply with the disclosure requirements identified in the attached Exhibit C, incorporated into the Agreement by this reference.

  • Governmental Consent No governmental orders, permissions, consents, approvals or authorizations are required to be obtained by the Company that have not been obtained, and no registrations or declarations are required to be filed by the Company that have not been filed in connection with, or, in contemplation of, the execution and delivery of, and performance under, the Transaction Documents, except for applicable requirements, if any, of the Securities Act, the Exchange Act or state securities laws or “blue sky” laws of the various states and any applicable federal or state banking laws and regulations.

  • Antitrust Assignment The Contractor and the State of Florida recognize that in actual economic practice, overcharges resulting from antitrust violations are in fact usually borne by the State of Florida. Therefore, the contractor hereby assigns to the State of Florida any and all claims for such overcharges as to goods, materials or services purchased in connection with the Contract.

  • Authorization Required Prior to Parallel Operation 2.2.1 The NYISO, in consultation with the Connecting Transmission Owner, shall use Reasonable Efforts to list applicable parallel Operating Requirements in Attachment 5 of this Agreement. Additionally, the NYISO, in consultation with the Connecting Transmission Owner, shall notify the Interconnection Customer of any changes to these requirements as soon as they are known. The NYISO and Connecting Transmission Owner shall make Reasonable Efforts to cooperate with the Interconnection Customer in meeting requirements necessary for the Interconnection Customer to commence parallel operations by the in-service date.

  • Short-Form Warning The Settling Entity may, but is not required to, use the following short-form warning as set forth in this subsection 2.3(b) (Short-Form Warning) or any substantially similar language so long as it is consistent with the implementing regulations, and subject to the additional requirements in subsections 2.5 and 2.6, as follows: WARNING: Cancer and Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx

  • EFFECTIVE DATE AND NOTICE OF NONLIABILITY This Agreement shall not be effective or enforceable until it is approved and signed by the State Controller or its designee (hereinafter called the “Effective Date”), but shall be effective and enforceable thereafter in accordance with its provisions. The State shall not be liable to pay or reimburse Contractor for any performance hereunder or be bound by any provision hereof prior to the Effective Date.

Time is Money Join Law Insider Premium to draft better contracts faster.